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Introduction
Mitochondria are organelles that are essential for numerous metabolic reactions, including the oxidative phosphorylations that provide non-photosynthetic eukaryotic cells with their major source of ATP. The mitochondrial inner membrane contains the respiratory chain complexes and ATP synthase, as well as numerous other proteins, such as transporters and translocators. This extremely high protein content makes the mitochondrial inner membrane a good model system to study how hydrophobic proteins from different origins can reach their final destination, acquire their proper topology and their assembly partners in a lipid bilayer.
Most of the proteins synthesized in the cytoplasm and imported into the mitochondrial membrane are dependent on the Tom and Tim translocases from the outer and inner membranes (for review see 1). Other factors are necessary to ensure the correct insertion of the small number of respiratory complex subunits that are encoded by the mitochondrial genome and inserted within the inner membrane. First, at least in Saccharomyces cerevisiae, specific translational activators bound to the membrane recognize the 5'-untranslated leaders of most mitochondrial mRNAs and probably contribute to localize mitochondrial translation in the vicinity of the membrane, facilitating subsequent membrane integration of the newly synthetised peptides (2) . The modulation of mitochondrial protein synthesis can also promote its coupling with membrane insertion (3) . Second, in eukaryotic mitochondria, Oxa1p is an important inner membrane component mediating membrane insertion of mitochondrial proteins and the export of some domains that have to be translocated into the inter-membrane space. In particular, Oxa1p could be crucial for the insertion and lateral exit of mildly hydrophobic transmembrane (TM) segments (4) and for the translocation of charged soluble domains (5).
Oxa1p is functionally conserved in higher eukaryotes (6, 7) and the Oxa1p family extends far beyond eukaryotic mitochondria since members are present in both bacteria, such as YidC, and in OMS1, high copy suppressor of yeast oxa1 mutants 4 its soluble domain within the inter-membrane space (13) (14) (15) (16) . In Escherichia coli, YidC interacts with the Sec system to function as a membrane insertase; in particular YidC is required for the insertion of ATPase subunits (9, (17) (18) (19) . In Arabidopsis chloroplasts, the Alb3 protein mediates the insertion of the light antenna complexes into the thylakoid membrane (20) . The Chlamydomonas Alb3 is also required for efficient assembly of photosystem II (21) . The Oxa1, YidC and Alb3 proteins share modest sequence homology but show a conserved structure, with five or six TM segments interrupted with hydrophilic loops located on either side of the membrane (22, 23) . YidC contains six TM domains and both its C-terminus and N-terminus are located in the cytoplasm. In eukaryotes, Oxa1p-type proteins show a N-out C-in topology (24) and five TM domains, with a long basic C-terminal tail.
In an effort to analyze the domains of Oxa1p and to examine how its structure relates to its function and the interaction with its substrates, we have introduced point mutations and large deletions into various domains of the protein, that are located either in the membrane, the intermembrane space, or the matrix. We find that mutating two TM residues specific of the eukaryotic members of the family specifically affects cytochrome c oxidase activity. In addition, the two matrix regions of Oxa1p appear dispensable independently, but their simultaneous removal causes a severe respiratory deficiency. These mutants led to the isolation of a high copy suppressor, OMS1, which encodes a mitochondrial inner membrane protein of the methyl-transferase family. The suppression mechanism has been investigated and its functional implications are discussed. -1 his3-11,15 trp1-1 leu2-3,112 can1-100 . CW04 is the wild-type strain (11), NBT1 is the oxa1::LEU2 strain (6) and NBT3 the oxa1∆::URA3 strain (12) . The thermosensitive strain oxa1-ts1402 strain (25) where leucin 240 of Oxa1p is substituted by serine was constructed by R.A. Stuart and provided by J.M. Herrmann (14) . The ∆afg3 strain (afg3::HIS3) was from A. Tzagoloff. Media and genetic techniques were as described ((11).
Subcloning and site-directed mutagenesis. The 3 kb SacI KpnI fragment containing the OXA1
ORF was subcloned into the same sites of pRS416, a centromeric plasmid (26) , to yield pNB160.
Mutant DNA fragments were obtained by two step PCR as described (27) . In mutant WW>AA, codons 128-129 (TGG TGG) were replaced by GCA GCT, creating both a PstI and a PvuII site with the flanking wild-type nucleotide. Codon 140 (CGA) encoding arginine, was changed to GCA (A), creating an HpaI site, or to GAA (E). Codon 332 and 353 were changed from AAA (lysine) to the stop codon TAA, and codon 376 was altered from TTA (leucine) to GTA. Simultaneously, a NcoI, HpaI or SpeI site was created downstream the stop codons 332, 353 or 376 respectively.
Deletion of the 43 codons of L1 created an HpaI site. Deletion of L2 or TM4-5 removed 25 and 33 codons respectively. Mutant OXA1 fragments were subcloned into pNB160 using various restriction sites located throughout the OXA1 ORF. All the plasmids generated were verified by sequencing the regions coming from PCR amplification and the cloning junctions. For some mutants the SacI KpnI 3kb fragment was subcloned into the high copy URA3 vector YEp352 (28).
Homologous recombination.
The oxa1 mutations were integrated into the genome. However, as the different C-terminal truncations showed a similar phenotype on plasmid, only the largest one, K332*, was chosen for homologous integration into the yeast genome. The resulting oxa1 mutation is identical to that carried by the oxa1 1-331 mutant used in (16 Figure 3A ) and subcloned into the same sites of vector Yep352 (28) . This new plasmid, pNB229, still carried the suppressor activity and contains two XbaI sites, 554 bp apart, surrounding the third methyl transferase motif coding region of OMS1 (motif II, see Figure 6A ). A PCR primer was designed, that contained the first XbaI site and a modified motif II coding region: codon 326, coding for aspartate, was changed from GAT to GCA (alanine); in addition the following codon was altered from ACT (threonine) to TCT (serine), which allowed the creation of a NsiI while still coding an hydroxylated amino-acid at position 327. Previous studies have shown that this position did not matter for activity (29) . A mutated version of the XbaI 554 bp fragment was generated by PCR amplification and subcloned in frame into the XbaI sites of pNB229 to replace the wild-type fragment. In this new plasmid pNB230, the expected mutation was verified by the presence of the NsiI site followed by sequencing of the cloned XbaI fragment and junctions. 3 5 labeling. Cells were grown either in complete or minimal galactose medium and mitochondria were purified as described in (31) . Swelling and protease K treatment of mitochondria were carried out as described in (32) . Mitochondria were analyzed by SDS-PAGE followed by blotting onto a nitrocellulose membrane and hybridization with various antibodies: anti-Cox2p and anti-porin (Molecular Probes), anti-Cytochrome c1 (raised in our lab against a fusion protein ProAapocytochrome c1 expressed in E. coli), anti-Atp2p and anti-Atp4p (J. Velours,), anti-c-Myc (J.M.
Galan), anti-Arg8p (T.D. Fox). Immuno-detection was carried out using the standard chemiluminescence method. To measure the cytochrome c oxidase activity, the oxidation of previously reduced cytochrome c was followed spectrophotometrically at 550 nm according to (33) .
Ubiquinol cytochrome c oxidase activity (bc1 activity) was measured according to (34) .
Oligomycin-sensitive ATPase activity was measured by colorimetric determination of inorganic phosphate released from ATP according to (35 To investigate the function of the different domains of Oxa1p, mutations were created in the gene on a centromeric plasmid using a PCR-based site directed mutagenesis strategy, and then integrated at the chromosomal OXA1 locus ( Figure 1A ). First, missense mutations were introduced in, or close to the sequences encoding the first hydrophobic segment TM1: the pair of tryptophans 128-129, specific to eukaryotic Oxa1p/Alb3p-type sequences was changed to a pair of alanines (WW>AA), whereas the basic arginine 140 adjacent to TM1 was substituted by either the neutral alanine (R140>A) or the acidic glutamate residue (R140>E). Second, non-sense mutations were placed in the 3' end of OXA1 to generate three different truncations of the C-terminal tail of Oxa1p
(K332*, K353*, K376*). Third, large deletions were made either within loop 1 (∆L1) or loop 2 (∆L2), or to eliminate TM4 and TM5 by fusing loop 3 to the C-terminal tail (∆TM4-5).
The phenotypes of these various mutants were analyzed on respiratory media containing different non-fermentable carbon sources (ethanol/glycerol/lactate), which cannot sustain growth of the null mutant ∆oxa1 ( Figure 1B ). The missense mutations WW>AA in TM1 led to a very strict thermosensitive and slightly cryosensitive phenotype on non-fermentable medium, whereas modification of R140 (R>E, R>A) only conferred a cryosensitive phenotype on lactate medium.
Like the ∆oxa1 mutant, ∆L2 and ∆TM4-5 did not grow at all on these non-fermentable media. ∆L1
and truncations of the C-terminal tail of Oxa1p were indistinguishable from the wild-type at 28°C
although K332* showed some weak sensitivity to either high or low temperatures. It was striking that ∆L1 and K332* gave mild phenotypes while deleting such large matrix parts of the protein, so we constructed a double mutant ∆L1-K332* by combining both matrix mutations. This ∆L1-K332* mutant does not grow on non-fermentable medium. The mutants were subjected to biochemical analysis to determine both the steady state-level and size of the Oxa1p variants, and the effect on respiratory complex biogenesis. Except for ∆L2, in which the Oxa1p protein was repeatedly undetectable, the mutated Oxa1p could be detected in purified mitochondrial extracts in all the other mutants, although always in lower steady-state levels than in the wild-type ( Figure 2A ). We could find no correlation between the levels of Oxa1p variants and either the nature of the mutation or the strength of the phenotype: rather Oxa1p levels seemed extremely sensitive to any type of mutation. This could be due to the fact that Oxa1p is known to facilitate its own insertion (37) , and is very sensitive to proteases (38) . For all mutants, the observed size of the Oxa1p variants was compatible with the predicted size. Strikingly, the level of the Oxa1p variant observed in WW>AA was similar whether at permissive or restrictive temperature, suggesting that the mutated protein activity rather than its accumulation is affected by high temperature. In addition, the level of the ∆L1-K332* was similar to that of the two single mutants, showing that the large double deletion did not further destabilize Oxa1p.
Effect of the various mutations
In absence of Oxa1p, the N-tail translocation of the Cox2p precursor into the intermembrane space is blocked (25) . Consequently, the maturation of pre-Cox2p cannot occur and the unprocessed precursor is rapidly degraded. The new mutants were subjected to S 3 5 labeling of the mitochondrial proteins at 28°C ( Figure 2B ). As usual in this strain background, the cytochrome b labeling signal is stronger when Oxa1p function is affected (Lemaire C., unpublished data).
Whereas Cox2p was entirely matured in ∆L1 and K332*, ∆L2 and ∆TM4-5 behaved like ∆oxa1 mutants. Interestingly, R>A and WW>AA, that show wild-type growth on non-fermentable carbon source at 28°C, were partly defective in pre-Cox2p processing, similarly to ∆L1-K332* which exhibits a strong respiratory deficient phenotype. This suggests that the respiratory growth deficiency of ∆L1-K332* is due to respiratory chain biogenesis defect that is distinct from preCox2p membrane insertion.
The effect of these oxa1 mutations on respiratory complex assembly was further analyzed by combining immunodetection experiments and respiratory enzyme activity measurements on OMS1, high copy suppressor of yeast oxa1 mutants 10 the wild-type, whereas ∆TM4-5 was similar to the ∆oxa1 mutant. ∆L1-K332* grown at 28°C and WW>AA grown at restrictive temperature showed an intermediate phenotype. Second, respiratory enzyme activity measurements were performed for the two latter mutants (Table 1) . ∆L1-K332* exhibited a dramatic 90% decrease in cytochrome c oxidase activity, and at least a 50% decrease in bc1 and ATPase activities. At restrictive temperature, WW>AA presented a specific defect of cytochrome c oxidase while the ATPase and the bc1 activities were nearly wild-type. Thus, all the biochemical analyses showed that ∆L1-K332* has a pleiotropic phenotype that reflects the requirement of the matrix domains for the biogenesis of the three respiratory complexes, whereas WW>AA specifically affects cytochrome c oxidase formation at high temperature.
YDR316w/OMS1 is a high copy suppressor of partial oxa1 defects that genetically interacts with OXA1
Contrary to the ∆oxa1 mutant, WW>AA presented spontaneous reversion events of the respiratory deficiency at 36°C and thus appeared less stringent than ∆oxa1. This lead us to search for high copy suppressors of WW>AA even though no high copy suppressors of ∆oxa1 have ever been isolated. A genomic library cloned in a high copy vector was introduced into WW>AA cells and colonies presenting a slow growth phenotype on non-fermentable carbon sources were further analyzed. One of them contained a plasmid carrying a 3.9 kb fragment of chromosome IV that conferred suppression after re-transformation of both the original mutant WW>AA and the ∆L1-K332* mutant, although only at 28°C for ∆L1-K332* ( Figure 3A and data not shown). This 3.9 kb fragment contained two entire ORFs, YDR316w and IPK1/YDR315c, together with the 5' region of
YDR314c. Subcloning and disruption showed that the gene responsible of the suppression was
YDR316w, an ORF of unknown function, that we called OMS1 for "Oxa1 Multicopy Suppressor"
( Figure 3A ).
In theory, Oms1p could compensate only for all/some oxa1 deficiencies, or it could generally improve the non-fermentable growth efficiency of many conditional respiratory mutants.
To decide between these possibilities, we determined the allele specificity of the suppression.
Several oxa1 mutants were transformed with the plasmid carrying OMS1 and tested for growth on glycerol medium at 28 or 36°C (not shown). While ∆oxa1, ∆L2 or ∆TM4-5 were clearly not suppressed, the mutant oxa1-ts1402 corresponding to a thermosensitive substitution of leucin to serine (25) was suppressed, like WW>AA and ∆L1-K332* (data not shown). Mitochondria were purified from the ∆L1-K332* transformants carrying the OMS1 plasmid and Western blot analysis revealed that over-expression of OMS1 slightly increased the steady-state level of Cox2p ( Figure   3B ). Second, to analyze the gene specificity of the suppression, we also transformed various nuclear or mitochondrial mutants showing either thermosensitive or leaky respiratory phenotypes. We found that the ∆mba1 (39), ∆nam1 (40), cox2-10 (41) and cbs2-223 (42) mutants were not suppressed (not shown). Thus, the multicopy suppressor phenotype of OMS1 is specific to some alleles of OXA1.
In order to study the function of Oms1p, we deleted the gene. The doubling time of the ∆oms1 cells was slightly longer than that of the isogenic wild-type cells grown in liquid glycerol medium (4h instead of 2h30 for the wild-type at 28°C). No synergistic growth defect was detected when ∆oms1 was combined with ∆oxa1. However, a strong interaction was observed in a WW>AA thermosensitive background, the combination of the WW>AA and ∆oms1 mutations prevented growth on non-fermentable medium at 28°C ( Figure 3C ), and not only at 36°C as in the WW>AA single mutant ( Figure 1B ). This growth defect at 28°C was complemented by introduction of the OMS1 plasmid (not shown). Thus the absence of Oms1p appears only midly deleterious for respiration except when combined with a specific oxa1 mutation.
OMS1 encodes an integral inner mitochondrial membrane protein inserted independently of Oxa1p with a N-in C-out orientation.
Oms1p is a 471-residue protein that contains two domains separated by a predicted TM To determine whether Oms1p was located in the mitochondria, we generated a strain where the genomic wild-type OMS1 gene was fused just before the stop codon to the c-Myc epitope. As a control, this tagged derivative was cloned on a high copy plasmid and this construction was still able to suppress the growth defect of the ∆L1-K332* ( Figure 4A ). Purified mitochondria from the It was tempting to hypothesize that this increase in the ∆L1-K332* steady-state level by
Oms1p could account for the suppression. In this case, direct overexpression of the mutated oxa1
genes from a high copy plasmid would be predicted to compensate for the deletion of OXA1. We found that the ∆L1-K332* and WW>AA mutants could compensate for OXA1 deletion when expressed from a high copy vector, even at 36°C ( Figure 5B ).
In a similar way, overexpression of OMS1 could act on the wild-type Oxa1p. It is known that overexpression of OXA1 suppresses the respiratory defect due to the absence of Afg3p, a protease facing the matrix side of mitochondria (44, 45) . Thus we transformed the OMS1 plasmid in the ∆afg3 mutant and observed that the ∆afg3 respiratory deficiency is clearly compensated by overexpression of OMS1 ( Figure 3C ). This suggests that the suppression of ∆afg3 mediated by high copy of OMS1 occurs through stabilization of the wild-type Oxa1p. Overproduction of the Oxa1p variants WW>AA or ∆L1-K332*, or of the CYT1-1 suppressor of the OXA1 deletion (46) could not overcome the respiratory deficiency of ∆afg3 cells. Taken together, our results indicate that overproduction of Oms1p affects the accumulation of both wild-type and mutant Oxa1p. Oms1p belongs to the family of yeast methyl-transferases, based on its good match with the four typical motifs conserved in a large number of these enzymes (43) ( Figure 6A ). Thus, it was of interest to determine whether the methyl-transferase activity of Oms1p was involved in the suppression. However, to be conclusive, a mutagenic analysis should not lower Oms1p steady state level, since Oms1p-mediated suppression functions only as high dosage.
In rat guanidinoacetate methyl-transferase, a widely conserved aspartate residue in the third conserved motif (motif II) has been shown to be crucial for the activity of the enzyme. Mutation into glutamate substantially lowered the activity, whereas mutation into alanine led to inactivation (29) . In addition, neither the secondary and tertiary structures of the enzyme nor its stability were affected. It was also shown that conservative change of the residues flanking the aspartate did not affect either the activity or stability of the enzyme (29) .
We introduced by PCR-mediated mutagenesis a mutation in Oms1p motif II ( Figure 6A ).
The aspartate was changed to alanin, and for convenience, the threonin adjacent to the aspartate was changed to serine, i.e. a conservative change. The mutant gene was cloned on a high copy plasmid and transformed into the ∆L1-K332* mutant, together with the wild-type control plasmid.
Whereas the suppression was clearly seen in four days with wild-type plasmid, the mutant plasmid was unable to suppress, like the empty vector ( Figure 6B ).
To make sure that the mutant protein was indeed expressed and stable, we tagged with the c-Myc epitope sequence both the wild-type and mutant OMS1 genes carried on the high copy plasmid and measured the accumulation of the tagged protein in purified mitochondria. Western blot analysis showed that the mutation in Oms1p motif II did not modify its stability ( Figure 6C ), thus demonstrating that the loss of the suppression was indeed due to the mutation itself, and not to a lower dosage of Oms1p.
Together these results show that Oms1p methyl-transferase conserved motif II is essential for the suppression of oxa1 mutations, and strongly suggest that Oms1p is indeed a methyltransferase and that this enzymatic activity is responsible of the suppression. In E. coli, the gene encoding the YidC homolog of Oxa1p has been mutated to study the role of the different domains, and the authors concluded that none of the hydrophilic periplasmic or cytoplasmic domain residues were important for YidC activity (47) . The present study as well as previous work (15, 16, 25) charges, which are predicted to be part of the TM segment, and could represent a natural equivalent of the Cyt1-1p suppressor. Three lines of evidence suggest that this is not the case. First, when we attached the c-Myc epitope to the middle of the OMS1 ORF to produce a truncated Oms1p-c-Myc, containing the TM segment but lacking the methyl-transferase domain, the strong suppression of the oxa1 mutants was lost (data not shown). However we were not able to detect the tagged truncated protein, preventing any definite conclusion to be drawn. Second, we found that Oms1p overproduction cannot compensate for the complete absence of Oxa1p, whereas Cyt1-1p does.
Third, and most importantly, we found that the mutation of a conserved methyl-transferase motif located more than 200 residues downstream the TM segment abolishes the suppression. Thus the two suppression mechanisms clearly differ: the enzymatic activity and not the TM segment appears to be responsible of the suppression by Oms1p.
In addition, like OXA1 (44) and contrary to CYT1-1, OMS1 overexpression is able to compensate for the absence of the matrix protease Afg3p. This suppression can be linked to the observation that overexpression of OMS1, similarly to overexpression of the wild-type OXA1 gene, increases 4 fold the steady state level of the truncated ∆L1-K332* Oxa1p. One possibility would be that OMS1 overexpression can stabilize not only the truncated but also the wild-type Oxa1p, and thus mimicks an elevated copy number of OXA1, thereby mediating ∆afg3 suppression. Similarly, the increase in the steady-state level of the truncated Oxa1p when OMS1 is overexpressed seems sufficient to explain the improved growth of the ∆L1-K332* mutant, because overproduction of the truncated ∆L1-K332* protein can compensate for the complete absence of Oxa1p.
While the increase of wild-type or mutant Oxa1p can account for the observed suppressions, the question remains of how these increases in steady-state levels are mediated. We observed that overexpression of wild-type OXA1 stabilizes the mutant ∆L1-K332* protein. Since
Oxa1p is known to facilitate its own insertion (37) and to exist as homotetramers (50), a reasonable hypothesis is that the wild-type Oxa1p could form a complex with the ∆L1-K332* variant and stabilize it, and/or promote its membrane insertion. In the case of OMS1 overexpression, a post- Cyt1p signal corresponds to the direct detection of heme c chemiluminescence (52) . C. A diploid homozygous for the thermosensitive oxa1 allele encoding Oxa1p-WW>AA and heterozygous for the deletion of OMS1 was subjected to sporulation and asci were microdissected. Growth of the spores was compared on complete glucose medium supplemented (Glc+ G418) or not (Glc) with the G418 antibiotic that selects for ∆oms1, and on non-fermentable glycerol medium (Gly 28°C). 
